Gerbera Therapeutics Inc
General
Total Cases3
Active Cases3
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/16/24 | REDACTED VERSION of [287] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024) | |
| 09/16/24 | REDACTED VERSION of [1528] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024) | |
| 09/16/24 | DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) | |
| 09/16/24 | DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [296] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [287] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [287] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) | |
| 09/13/24 | [SEALED] Joint Letter to The Honorable Richard G. Andrews, from Novartis and MSN, regarding bond pending appeal. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Exhibit E, # [6] Exhibit F, # [7] McDuff Declaration, # [8] Chintapally Declaration, # [9] Certificate of Service) (Silver, Daniel) Modified on 9/16/2024 (nms). (Entered: 09/13/2024) | |
| 09/13/24 | NOTICE to Take Deposition of Jonathan W. Steed, Ph.D. on September 17, 2024 filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/13/2024) | |
| 09/13/24 | NOTICE to Take Deposition of Richard L. McCreery, Ph.D. on September 18, 2024 filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/13/2024) | |
| 09/13/24 | REDACTED VERSION of [287] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H)(Gattuso, Dominick) (Entered: 09/13/2024) | |
| 09/13/24 | [SEALED] Joint Letter to The Honorable Richard G. Andrews, from Novartis and MSN, regarding bond pending appeal. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Exhibit E, # [6] Exhibit F, # [7] McDuff Declaration, # [8] Chintapally Declaration, # [9] Certificate of Service) (Silver, Daniel) Modified on 9/16/2024 (nms). (Entered: 09/13/2024) | |
| 09/13/24 | NOTICE to Take Deposition of Jonathan W. Steed, Ph.D. on September 17, 2024 filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/13/2024) |